Inflammaging: how chronic low-grade inflammation accelerates ageing

Most people think of inflammation as the hot, swollen, angry kind — the sort that makes a sprained ankle look like a grapefruit and then gradually disappears. That kind is fine. Useful, even. The version nobody tells you about is considerably quieter, considerably slower, and considerably more relevant to how you age.

In the late 1990s, Italian immunologist Claudio Franceschi began noticing something unusual in the biology of older adults: chronically elevated levels of inflammatory proteins — not enough to cause obvious disease, but persistently above the baseline you’d expect in a healthy body. A kind of immune activation that never quite switched off.

He coined the term inflammaging in 2000, in a paper published in the Annals of the New York Academy of Sciences. The concept — chronic, low-grade, systemic inflammation as both a marker and a driver of biological aging — has since become one of the most well-supported frameworks in longevity science, appearing in research across cardiology, neurology, metabolism, and immunology.

The uncomfortable summary: this slow-burning inflammatory state underlies nearly every condition we associate with getting old. And it starts accumulating long before you’d notice anything clinically.

Inflammation is supposed to be a feature, not a bug

Acute inflammation is genuinely good. When you get a cut, inhale a pathogen, or damage a muscle during a training session, your immune system mounts a fast, targeted response: white blood cells flood the area, cytokines coordinate the attack, and repair processes begin. It’s precise, temporary, and essential.

The same immune system that triggers this response is also supposed to produce specialized pro-resolving mediators — molecules that actively shut inflammation down once the threat is gone. The whole system is designed to go from baseline to response and back to baseline.

Inflammaging is what happens when “back to baseline” stops working properly. Inflammatory signals stay elevated. Immune cells stay partially activated. The body sits in a persistent low-level state of readiness — not enough to constitute acute illness, but enough, over years and decades, to cause significant cumulative damage.

Think of it like a smoke alarm that won’t reset. No fire, technically. Just the alarm going off at 20% volume indefinitely, which turns out to be its own problem.

The mechanisms behind it

Understanding why inflammaging develops helps explain why the lifestyle interventions that work actually work — and why there’s no single shortcut.

Cellular senescence is one of the primary drivers. Senescent cells — sometimes called zombie cells — are cells that have stopped dividing and should be cleared from tissue, but aren’t. Instead they accumulate and secrete a chronic inflammatory cocktail of cytokines, proteases, and growth factors called the Senescence-Associated Secretory Phenotype (SASP). Young bodies clear senescent cells efficiently via immune surveillance. With age, this clearance falters, and senescent cells accumulate — particularly in adipose tissue — each one continuously emitting pro-inflammatory signals.

Gut dysbiosis contributes significantly. The gut microbiome changes with age in ways that are generally unfavourable: microbial diversity decreases, species associated with intestinal barrier integrity decline. As the gut wall becomes more permeable, bacterial components like lipopolysaccharides enter systemic circulation, triggering ongoing immune activation that has no actual pathogen to resolve. The immune system is responding to something real — it’s just not something it can clear.

Visceral adipose tissue is immunologically active in a way that subcutaneous fat isn’t. It contains high concentrations of macrophages and secretes IL-6, TNF-α, and other inflammatory cytokines directly. Greater visceral fat accumulation means a larger ongoing inflammatory burden — which is one reason metabolic health markers and aging trajectories are so tightly coupled.

Mitochondrial dysfunction generates reactive oxygen species that trigger inflammatory signalling cascades. As mitochondrial quality control declines with age, this becomes another source of chronic immune activation — and one argument for why interventions that improve mitochondrial health (aerobic training, primarily) show up so consistently in anti-inflammaging research.

These mechanisms don’t operate independently. Inflammation promotes cellular senescence; senescent cells drive more inflammation. Gut dysbiosis contributes to visceral fat accumulation; visceral fat drives more inflammation. The loop is self-reinforcing, which is why addressing just one lever tends to produce modest results and addressing several simultaneously tends to produce meaningful ones.

What inflammaging actually causes downstream

A 2019 review in Nature Medicine by David Furman, Judith Campisi, and colleagues described chronic inflammation as a major driver of disease across the life span — appearing in the pathophysiology of cardiovascular disease, type 2 diabetes, neurodegeneration, cancer, and musculoskeletal decline. The evidence base at this point is substantial and fairly well-replicated.

The most direct causal demonstration came from the CANTOS trial, published in The New England Journal of Medicine in 2017. Researcher Paul Ridker and colleagues at Harvard Medical School tested canakinumab — a drug targeting IL-1β, a specific inflammatory cytokine — in 10,061 patients who had survived a heart attack and had elevated high-sensitivity CRP. The finding was direct: reducing inflammation, independent of any effect on cholesterol, significantly reduced subsequent cardiovascular events and cardiovascular mortality. The inflammation was doing something causal, not just marking that something was wrong.

The neurological picture is similarly concerning. Elevated IL-6 and CRP in midlife predict accelerated cognitive decline and increased Alzheimer’s risk in longitudinal studies tracking people over decades. Neuroinflammation — driven partly by systemic processes, partly by brain-specific immune cells (microglia) becoming chronically activated — is increasingly understood as a key contributor to neurodegeneration rather than a mere accompaniment to it.

The muscular connection is particularly relevant for anyone monitoring their longevity metrics. Inflammatory cytokines — TNF-α and IL-6 especially — directly interfere with muscle protein synthesis and accelerate muscle mass loss. Inflammaging and sarcopenia amplify each other: less muscle means less metabolically active tissue to help process inflammatory signals; more inflammation means faster muscle degradation. This is one reason grip strength is such a sensitive longevity biomarker — it’s measuring the downstream output of a system that inflammaging erodes at the source.

How to test your inflammatory status

High-sensitivity CRP (hs-CRP) is the most accessible starting point. It’s a standard blood test most GPs can order on request. Population reference ranges:

• Under 1 mg/L: Low inflammatory state — this is where you want to be, ideally below 0.5
• 1-3 mg/L: Average for the general population — not an immediate alarm, but indicating background inflammation
• Above 3 mg/L: Elevated chronic inflammation — meaningfully associated with higher risk for most age-related conditions

One important caveat: acute illness, injury, intense recent exercise, or even a minor infection can transiently spike CRP significantly. A single high reading needs context. The signal is your resting baseline over time, not a snapshot during a stressful week.

IL-6 is a more direct inflammatory mediator and is increasingly measured in comprehensive health assessments, though not yet standard in routine panels. The neutrophil-to-lymphocyte ratio, calculable from a standard complete blood count, is another useful proxy for chronic inflammatory load that requires no additional testing beyond what’s often already done.

What actually moves the needle

The lifestyle interventions with the best evidence for reducing chronic inflammation are, with very few exceptions, exactly the ones that appear throughout the longevity literature generally. Bit repetitive, but that’s actually the point — the fundamentals are fundamental because they address multiple mechanisms simultaneously.

Exercise

Consistent moderate aerobic exercise is among the most effective anti-inflammatory interventions known, with benefits documented across decades of research. A 2011 review in Nature Reviews Immunology by Michael Gleeson and colleagues outlined the mechanisms: exercise reduces visceral fat (directly lowering the adipokine-driven inflammatory burden), promotes release of anti-inflammatory myokines from contracting muscle (particularly IL-10 and IL-1 receptor antagonist), improves mitochondrial quality, and stimulates autophagy — the cellular clearance pathway that helps remove senescent cells and damaged organelles.

Zone 2 cardio appears particularly effective for long-term inflammatory load reduction, which fits with what the HRV research also shows about sustained aerobic training building parasympathetic resilience. High-intensity training without adequate recovery can temporarily elevate inflammatory markers — so the goal isn’t exhaustion, it’s consistency over months and years. Regular walkers maintain lower CRP than intermittent hard trainers who are chronically under-recovered.

Dietary pattern

No single anti-inflammatory food makes a measurable dent on its own. The Mediterranean dietary pattern as a whole has the strongest and most consistent evidence for reducing hs-CRP and IL-6. The mechanisms are multiple: oily fish provide EPA and DHA, which are direct precursors to specialized pro-resolving mediators (resolvins and protectins) that actively shut down inflammatory processes; polyphenols in vegetables, fruits, and olive oil inhibit NF-κB — the master transcription factor for inflammatory gene expression; dietary fibre supports the gut microbiome composition associated with lower systemic inflammation.

Practically: oily fish 2-3 times per week, extra virgin olive oil as the primary cooking fat, colourful vegetables at most meals, legumes regularly, walnuts and seeds. Ultra-processed foods are consistently associated with higher inflammatory markers across observational and intervention studies — not because of any single ingredient, but because of the overall composition and what they displace from the diet. The longevity diet overview goes deeper on the evidence if you want the full picture.

Sleep

The relationship between sleep and inflammation is bidirectional and well-documented. Chronic short sleep — even moderate restriction to around 6 hours per night — produces measurable elevations in IL-6 and CRP in otherwise healthy adults within days. The mechanism involves both cortisol dysregulation (elevated evening cortisol from sleep debt impairs inflammatory resolution) and disruption of the parasympathetic-dominant nighttime state during which immune regulation and cellular repair predominantly occur.

Seven to nine hours, with consistent timing, appears to be the optimal range. Sleep timing matters almost as much as duration — irregular sleep schedules disrupt circadian immune regulation patterns even when total hours look adequate. There’s a reason every longevity intervention study ends up controlling for sleep as a major confounding variable.

Stress management

Chronic psychological stress sustains HPA axis activation and sympathetic nervous system tone, both of which drive pro-inflammatory signalling. Sustained cortisol elevation paradoxically sensitises tissues to inflammatory signals even while blunting some acute immune responses — a pattern associated with higher baseline CRP in people under chronic work, relationship, or financial stress.

Interventions with reasonable controlled-trial evidence include mindfulness-based stress reduction (MBSR), consistent exposure to natural environments, and — possibly underappreciated — social connection. Loneliness and social isolation are associated with meaningfully elevated inflammatory markers across multiple large longitudinal studies, independent of other health behaviours. That’s either reassuring (there’s something concrete you can do) or slightly alarming (it’s not just diet and exercise), depending on how your weekends currently look.

Omega-3 fatty acids

Of the supplements with anti-inflammatory claims, omega-3 fatty acids (EPA and DHA) have by far the most robust evidence. Philip Calder’s 2017 review in Biochemical Society Transactions detailed the mechanistic pathway: EPA and DHA are direct precursors to the specialized pro-resolving mediators that actively terminate inflammatory cascades. The effect on hs-CRP from supplementation is modest — roughly 0.2-0.5 mg/L — but real, consistent, and dose-dependent. Around 2-3g per day of combined EPA and DHA appears to be the meaningful threshold, which is approximately what you’d get from 2-3 oily fish servings per week.

Everything else — curcumin, resveratrol, the various “anti-inflammatory” botanical supplements — has either weak evidence, evidence that doesn’t replicate across studies, or bioavailability issues that make interpretation complicated. Interesting in some cases, but not the lever to rely on.

Common misconceptions

“Anti-inflammatory” on a food label is meaningless. The term has no regulatory definition and appears on products ranging from genuinely useful (wild salmon) to irrelevant (certain sparkling waters). What matters is dietary pattern over months and years — not individual products that have claimed the label.

Post-exercise inflammation is not inflammaging. The soreness and elevated cytokines after a hard session are part of a healthy adaptation process — acute, appropriate, and followed by resolution. This is precisely the mechanism that inflammaging has broken. Training hard is anti-inflammatory in the chronic sense even when it’s temporarily pro-inflammatory in the acute sense. These are different things.

A single CRP test is context-dependent. If you had a respiratory infection two weeks ago, your CRP is probably still elevated from that. Test during a stable baseline period, and track trends over months rather than reading too much into individual data points.

You can’t supplement your way out of a pro-inflammatory lifestyle. Omega-3s are genuinely useful, but they don’t offset a diet high in ultra-processed foods, chronic sleep deprivation, or years of unmanaged stress. The interventions work best as a system.

The Sarvita angle

Inflammaging is the sort of thing that accumulates invisibly for years before it shows up as anything you’d notice clinically. By the time a doctor flags your CRP, elevated inflammatory markers have probably been present for a decade or more. This isn’t alarmism — it’s just how slow biological processes tend to work.

It’s the same argument for tracking biological age rather than waiting for a disease diagnosis. HRV trend, muscle mass trajectory, and metabolic markers don’t measure inflammation directly, but they’re sensitive to the same underlying processes. A declining HRV trend alongside deteriorating body composition and elevated resting heart rate tells a story about the inflammatory environment even before any individual alarm has tripped.

The practical goal isn’t obsessive monitoring. It’s having enough signal to act early — and acting on the interventions that the evidence actually supports.

The practical summary

Inflammaging is not an obscure molecular curiosity. It’s the slow inflammatory background noise that shapes how quickly you accumulate the diseases of aging, how well you maintain muscle and cognitive function, and how long your health span actually lasts.

The interventions are not glamorous: consistent aerobic exercise, a diet close to the Mediterranean template, seven to nine hours of quality sleep, and some form of chronic stress management that actually works for you rather than looking good in principle. If you want a baseline, ask your GP for a high-sensitivity CRP test — it’s a routine, cheap blood marker that tells you quite a lot for very little effort.

What’s striking about the inflammaging literature is how consistently the same evidence converges from different study designs, different populations, and different decades of research. That kind of convergence is as close to certainty as longevity science tends to offer.

Anyway. Start with the basics, then see where you actually are. The link’s there if you want the deeper reading.